Transdermal and Microneedle Drug Delivery 2024 Conference

November 11-12, 2024 - London, United Kingdom

Join the 3rd annual Transdermal and Microneedle Drug Delivery conference - leading the transition of drug delivery beyond the needle.

Collaborate across a high-level 2-day programme.

Collaborate with forward-thinking drug development and delivery experts to discuss case studies and real-world examples of delivery R&D, vaccine application, and diversifying capabilities.

Transdermal and Microneedle Array Patches (MAPs) are one of the exciting fields and fast-growing in pharmaceutical development. Offering a combination of unrivalled potency - from increased community access, to consistent long-term delivery and diagnostic capabilities - this technology is at the vanguard of increasing efficacy and global access to transformative products.

Highlights include:

  • Successes in clinical data and vaccine delivery
  • Innovative capabilities and applications of transdermal and microneedle patches
  • Manufacturing challenges and progress
  • Insights and Q&A opportunities with key regulators

2023 Speakers Included

  • Ajoy Chakrabarti, Portfolio & Platform Lead, Polio, Bill & Melinda Gates Foundation
  • Clemens Gunther, Director, Senior Expert Nonclinical Safety, Bayer AG
  • Gareth Sheridan, CEO, Nutriband Inc
  • Jake Lombardo, Co-Founder & CEO, Anodyne Nanotech, Inc
  • James Birchall, Professor of Pharmaceutical Sciences and Deputy Head of School, Cardiff University
  • Jamie Oliver, Chief Medical Officer, Starton Therapeutics
  • Jeffrey Blue, Executive Director of Vaccine Drug Product Development and New Technologies, Merck
  • Mateusz Hasso-Agopsowicz, Technical Officer, World Health Organization
  • Megan Polidano, Head of Regulatory Affairs, Vaxxas
  • Michael Schrader, Co-Founder & CEO, Vaxess Technologies
  • Muhammet Avcil, Managing Director, Imperial BioScience
  • Sanjiv Sharma, Senior Lecturer in Medical Engineering, Swansea University
  • Seong-O Choi, Chief Scientific Officer, QuadMedicine, Inc.
  • Simona Gallorini, Expert Scientist in Advanced technologies, GSK Vaccines
  • Tanima Sinha, Lead Interdisciplinary Scientist, HHS/ASPR/BARDA
  • Tycho Speaker, Director, Drug Delivery and Biomaterials, AbbVie

The full agenda is not yet available for this event.
Follow this event to receive an alert when the agenda becomes available.


Hilton London Kensington
179-199 Holland Park Ave, Kensington, W11 4UL
London, UK